Peer-influenced content. Sources you trust. No registration required. This is HCN.

Therapeutic Advances in Urology (TAU) delivers the highest quality peer-reviewed, open access, original research articles, reviews, and scholarly comment on pioneering efforts across all areas of urology. The journal is aimed at an international audience of clinicians, researchers and allied health practitioners in urology and related disciplines, providing an online forum for rapid dissemination of recent research and perspectives in this area.

Therapeutic Advances in Urology (TAU) covers themes including but not limited to:

  • Urologic oncology
  • Endourology
  • Andrology, Fertility and Sexual Health
  • Urogynaecology
  • Bladder disorders
  • Surgery
  • Uro-technology
  • Radiology
  • Urological education and training (including technological advances such as surgical simulation)

Review articles include expert opinion/perspective reviews (including single-drug and drug class reviews), narrative reviews and therapeutic area reviews. Systematic reviews, meta-analyses, postmarketing and health economic and pharmacoeconomic reviews are also welcomed. The appropriate EQUATOR Network reporting guidelines should be followed (e.g. CONSORT for randomized, controlled trials and PRISMA for systematic reviews/meta-analyses). The journal endorses the ICMJE requirement that clinical trials are registered in a WHO-approved public trials registry at or before the time of the first patient enrolment.

The Healthcare Communications Network is owned and operated by IQVIA Inc.

Click below to leave this site and continue to IQVIA’s Privacy Choices form